Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial
- PMID: 12472909
- DOI: 10.1046/j.1365-2796.2002.01059.x
Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial
Abstract
Objective: Cigarette smoking is associated with increased plasma homocysteine concentrations, endothelial dysfunction and arterial stiffening. Homocysteine per se induces endothelial dysfunction and arterial stiffening and might account, at least partly, for the vascular abnormalities observed in smokers. We sought to determine whether folic acid supplementation, by reducing plasma homocysteine concentrations, enhanced endothelial function and reduced arterial stiffness in smokers.
Design: Double-blind, randomized controlled, parallel-group, trial.
Setting: Academic medical centre.
Subjects: A consecutive sample of 24 healthy cigarette smokers (age 37.8 +/- 2.5 years, mean +/- SEM).
Intervention: Subjects were randomly assigned to 4-week folic acid 5 mg day-1 or placebo.
Main outcome measures: The following were measured before and after treatment: (i) peripheral vasoreactivity (forearm arterial blood flow, FABF) during intra-arterial administration of endothelium-dependent (acetylcholine 1.5, 4.5 and 15 microg min-1) and endothelium-independent (sodium nitroprusside 1, 2 and 4 microg min-1) vasodilators; (ii) carotid-femoral pulse-wave velocity (PWV); (iii) blood pressure (BP).
Results: Folic acid reduced homocysteine concentrations (10.8 +/- 0.6 vs. 8.2 +/- 0.5 micromol L-1, P < 0.001) and enhanced endothelium-dependent vasodilatation during each acetylcholine infusion rate (ratio between the FABF in the infused and control arm during increasing infusion rates at baseline 1.09 +/- 0.03 vs. 1.41 +/- 0.09 after treatment, P < 0.01; 1.39 +/- 0.07 vs. 1.83 +/- 0.12, P < 0.01; 1.65 +/- 0.16 vs. 2.72 +/- 0.36, P < 0.05) whilst endothelium-independent vasodilatation was unaffected. A significant fall in BP was also observed (mean BP 88 +/- 2 vs. 83 +/- 1 mmHg, P < 0.01). By contrast, PWV did not significantly change (8.4 +/- 0.3 vs. 7.8 +/- 0.4 m s-1). No significant changes in plasma homocysteine concentrations, FABF, BP, and PWV were observed in the placebo group. A multiple regression analysis showed that changes in folic acid plasma concentrations independently predicted both FABF changes during maximal acetylcholine-mediated vasodilatation (P < 0.01) and BP changes (P = 0.01).
Conclusions: Short-term folic acid supplementation significantly enhanced endothelial function and reduced BP in young chronic smokers. These effects were largely independent from the homocysteine lowering effects. Thus, a simple, nontoxic, and relatively inexpensive vitamin intervention might be useful in primary cardiovascular prevention in this high-risk group.
Similar articles
-
Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.Am J Hypertens. 2005 Feb;18(2 Pt 1):220-6. doi: 10.1016/j.amjhyper.2004.08.036. Am J Hypertens. 2005. PMID: 15752950 Clinical Trial.
-
Folic acid: a marker of endothelial function in type 2 diabetes?Vasc Health Risk Manag. 2005;1(1):79-83. doi: 10.2147/vhrm.1.1.79.58941. Vasc Health Risk Manag. 2005. PMID: 17319100 Free PMC article.
-
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial.Thromb Res. 2003 Apr 15;110(1):13-7. doi: 10.1016/s0049-3848(03)00295-0. Thromb Res. 2003. PMID: 12877903 Clinical Trial.
-
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3. Z Kardiol. 2004. PMID: 15252738 Review.
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. PMID: 14584018 Updated. Review.
Cited by
-
Current Evidence and Future Perspectives of the Best Supplements for Cardioprotection: Have We Reached the Final Chapter for Vitamins?Rev Cardiovasc Med. 2022 Nov 9;23(11):381. doi: 10.31083/j.rcm2311381. eCollection 2022 Nov. Rev Cardiovasc Med. 2022. PMID: 39076184 Free PMC article. Review.
-
The interaction between diet quality and cigarette smoking on the incidence of hypertension, stroke, cardiovascular diseases, and all-cause mortality.Sci Rep. 2024 May 29;14(1):12371. doi: 10.1038/s41598-024-62616-9. Sci Rep. 2024. PMID: 38811588 Free PMC article.
-
Cigarette smoking and cardiovascular disease incidence and all-cause mortality: the modifying role of diet quality.BMC Public Health. 2024 Apr 12;24(1):1021. doi: 10.1186/s12889-024-18468-z. BMC Public Health. 2024. PMID: 38609915 Free PMC article.
-
Methotrexate and cardiovascular prevention: an appraisal of the current evidence.Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231215213. doi: 10.1177/17539447231215213. Ther Adv Cardiovasc Dis. 2023. PMID: 38115784 Free PMC article. Review.
-
The Effect of Folic Acid Supplementation on Endothelial Function and Arterial Stiffness Markers in Adults: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2023 Sep 13;11(18):2524. doi: 10.3390/healthcare11182524. Healthcare (Basel). 2023. PMID: 37761721 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous